Skip to main content
Fig. 5 | BMC Complementary and Alternative Medicine

Fig. 5

From: Investigate the mechanisms of Chinese medicine Fuzhengkangai towards EGFR mutation-positive lung adenocarcinomas by network pharmacology

Fig. 5

Core genes prognostic validation in LUAD with EGFR-mutation cohort. a Kaplan-Meier survival curve of sensitive and resistance groups for overall survival. b RS distribution in all mutation patients. c AUC of ROC for predicting RS of OS (AUC = 0.853). d Kaplan-Meier survival curve of sensitive and resistance groups for disease free survival. e RS distribution in all mutation patients with disease free survival information. f AUC of ROC for predicting RS of DFS (AUC = 0.746)

Back to article page